share_log

Positive Earnings Growth Hasn't Been Enough to Get Hubei Kailong Chemical Group (SZSE:002783) Shareholders a Favorable Return Over the Last Three Years

Positive Earnings Growth Hasn't Been Enough to Get Hubei Kailong Chemical Group (SZSE:002783) Shareholders a Favorable Return Over the Last Three Years

在过去三年中,正收益增长不足以让湖北开龙化工集团(SZSE:002783)股东获得丰厚的回报
Simply Wall St ·  02/26 02:51

This week we saw the Hubei Kailong Chemical Group Co., Ltd. (SZSE:002783) share price climb by 14%. If you look at the last three years, the stock price is down. But on the bright side, its return of -17%, is better than the market, which is down 20%.

本周我们看到湖北开龙化工集团有限公司(SZSE:002783)的股价上涨了14%。如果你看看过去的三年,股价下跌了。但好的一面是,其回报率为-17%,好于下跌20%的市场。

Although the past week has been more reassuring for shareholders, they're still in the red over the last three years, so let's see if the underlying business has been responsible for the decline.

尽管过去一周令股东更加放心,但在过去三年中,他们仍处于亏损状态,所以让我们看看基础业务是否是造成下降的原因。

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

虽然市场是一种强大的定价机制,但股价反映了投资者的情绪,而不仅仅是潜在的业务表现。评估公司情绪变化的一种有缺陷但合理的方法是将每股收益(EPS)与股价进行比较。

During five years of share price growth, Hubei Kailong Chemical Group moved from a loss to profitability. That would generally be considered a positive, so we are surprised to see the share price is down. So it's worth looking at other metrics to try to understand the share price move.

在五年的股价增长中,湖北开龙化工集团从亏损转为盈利。这通常会被视为利好,因此我们惊讶地看到股价下跌。因此,值得研究其他指标来了解股价走势。

With a rather small yield of just 1.2% we doubt that the stock's share price is based on its dividend. We note that, in three years, revenue has actually grown at a 20% annual rate, so that doesn't seem to be a reason to sell shares. This analysis is just perfunctory, but it might be worth researching Hubei Kailong Chemical Group more closely, as sometimes stocks fall unfairly. This could present an opportunity.

由于收益率相当低,仅为1.2%,我们怀疑该股的股价是否基于其股息。我们注意到,在三年内,收入实际上以20%的年增长率增长,因此这似乎不是出售股票的理由。这种分析只是敷衍了事,但可能值得对湖北开龙化工集团进行更仔细的研究,因为有时股票会不公平地下跌。这可能带来机会。

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

您可以在下图中看到收入和收入随时间推移而发生的变化(点击图表查看确切值)。

earnings-and-revenue-growth
SZSE:002783 Earnings and Revenue Growth February 26th 2024
SZSE: 002783 收益和收入增长 2024 年 2 月 26 日

It's probably worth noting that the CEO is paid less than the median at similar sized companies. But while CEO remuneration is always worth checking, the really important question is whether the company can grow earnings going forward. This free interactive report on Hubei Kailong Chemical Group's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

可能值得注意的是,首席执行官的薪水低于类似规模公司的中位数。但是,尽管首席执行官的薪酬总是值得检查的,但真正重要的问题是公司未来能否增加收益。如果你想进一步调查该股,这份关于湖北开龙化工集团收益、收入和现金流的免费互动报告是一个很好的起点。

A Different Perspective

不同的视角

While it's never nice to take a loss, Hubei Kailong Chemical Group shareholders can take comfort that , including dividends,their trailing twelve month loss of 14% wasn't as bad as the market loss of around 17%. Longer term investors wouldn't be so upset, since they would have made 1.8%, each year, over five years. In the best case scenario the last year is just a temporary blip on the journey to a brighter future. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Even so, be aware that Hubei Kailong Chemical Group is showing 3 warning signs in our investment analysis , and 2 of those are a bit unpleasant...

尽管亏损从来都不是一件好事,但湖北开龙化工集团的股东可以放心,包括股息在内,他们过去十二个月的亏损为14%,没有市场损失17%左右那么严重。长期投资者不会那么沮丧,因为他们本可以在五年内每年赚1.8%。在最好的情况下,去年只是通往更光明未来之旅中的一个暂时阶段。我发现将长期股价视为业务绩效的代表非常有趣。但是,要真正获得见解,我们还需要考虑其他信息。即便如此,请注意,湖北开龙化工集团在我们的投资分析中显示了3个警告信号,其中2个有点令人不快...

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

当然,通过寻找其他地方,你可能会找到一笔不错的投资。因此,请看一下我们预计收益将增加的这份免费公司名单。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

请注意,本文引用的市场回报反映了目前在中国交易所交易的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发